Decision-Making in the Surgical Treatment of Breast Cancer: Factors Influencing Women's Choices for Mastectomy and Breast Conserving Surgery

Emily Catherine Bellavance, Susan Beth Kesmodel, Emily Catherine Bellavance, Susan Beth Kesmodel

Abstract

One of the most difficult decisions a woman can be faced with when choosing breast cancer treatment is whether or not to undergo breast conserving surgery or mastectomy. The factors that influence these treatment decisions are complex and involve issues regarding access to health care, concerns for cancer recurrence, and the impact of surgery on body image and sexuality. Understanding these factors will help practitioners to improve patient education and to better guide patients through this decision-making process. Although significant scientific and societal advances have been made in improving women's choices for the breast cancer treatment, there are still deficits in the decision-making processes surrounding the surgical treatment of breast cancer. Further research is needed to define optimal patient education and shared decision-making practices in this area.

Keywords: breast cancer; breast conserving surgery; contralateral prophylactic mastectomy; mastectomy; shared decision-making.

References

    1. Politi MC, Studts JL, Hayslip JW. Shared decision making in oncology practice: what do oncologists need to know? Oncologist (2012) 17(1):91–100.10.1634/theoncologist.2011-0261
    1. Pope TM, Hexum M. Legal briefing: shared decision making and patient decision aids. J Clin Ethics (2013) 24(1):70–80.
    1. Lerner B. The Breast Cancer Wars. New York, NY: Oxford University Press; (2001).
    1. Fisher B. Laboratory and clinical research in breast cancer – a personal adventure: the David A. Karnofsky memorial lecture. Cancer Res (1980) 40(11):3863–74.
    1. Fisher B, Jeong JH, Anderson S, Bryant J, Fisher ER, Wolmark N. Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med (2002) 347(8):567–75.10.1056/NEJMoa020128
    1. Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med (2002) 347(16):1233–41.10.1056/NEJMoa022152
    1. Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans V, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet (2005) 366(9503):2087–106.10.1016/S0140-6736(05)67887-7
    1. Simone NL, Dan T, Shih J, Smith SL, Sciuto L, Lita E, et al. Twenty-five year results of the national cancer institute randomized breast conservation trial. Breast Cancer Res Tr (2012) 132(1):197–203.10.1007/s10549-011-1867-6
    1. Arriagada R, Le MG, Rochard F, Contesso G. Conservative treatment versus mastectomy in early breast cancer: patterns of failure with 15 years of follow-up data. Institut Gustave-Roussy Breast Cancer Group. J Clin Oncol (1996) 14(5):1558–64.
    1. Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med (2002) 347(16):1227–32.10.1056/NEJMoa020989
    1. Litiere S, Werutsky G, Fentiman IS, Rutgers E, Christiaens MR, Van Limbergen E, et al. Breast conserving therapy versus mastectomy for stage I-II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial. Lancet Oncol (2012) 13(4):412–9.10.1016/S1470-2045(12)70042-6
    1. Bartelink H, Horiot JC, Poortmans P, Struikmans H, Van den Bogaert W, Barillot I, et al. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med (2001) 345(19):1378–87.10.1056/NEJMoa010874
    1. Vaidya JS, Wenz F, Bulsara M, Tobias JS, Joseph D, Baum M. Radiotherapy for breast cancer, the TARGIT-A trial – authors’ reply. Lancet (2014) 383(9930):1719–20.10.1016/S0140-6736(14)60830-8
    1. Churilla TM, Donnelly PE, Leatherman ER, Adonizio CS, Peters CA. Total mastectomy or breast conservation therapy? How radiation oncologist accessibility determines treatment choice and quality: a SEER data-base analysis. Breast J (2015) 21(5):473–80.10.1111/tbj.12449
    1. Smith GL, Xu Y, Shih YC, Giordano SH, Smith BD, Hunt KK, et al. Breast-conserving surgery in older patients with invasive breast cancer: current patterns of treatment across the United States. J Am Coll Surg (2009) 209(4):425–33.e2.10.1016/j.jamcollsurg.2009.06.363
    1. Voti L, Richardson LC, Reis IM, Fleming LE, Mackinnon J, Coebergh JW. Treatment of local breast carcinoma in Florida: the role of the distance to radiation therapy facilities. Cancer (2006) 106(1):201–7.10.1002/cncr.21557
    1. Nattinger AB, Kneusel RT, Hoffmann RG, Gilligan MA. Relationship of distance from a radiotherapy facility and initial breast cancer treatment. J Natl Cancer Inst (2001) 93(17):1344–6.10.1093/jnci/93.17.1344
    1. Athas WF, Adams-Cameron M, Hunt WC, Amir-Fazli A, Key CR. Travel distance to radiation therapy and receipt of radiotherapy following breast-conserving surgery. J Natl Cancer Inst (2000) 92(3):269–71.10.1093/jnci/92.3.269
    1. Greenberg CC, Lipsitz SR, Hughes ME, Edge SB, Theriault R, Wilson JL, et al. Institutional variation in the surgical treatment of breast cancer: a study of the NCCN. Ann Surg (2011) 254(2):339–45.10.1097/SLA.0b013e3182263bb0
    1. Dragun AE, Huang B, Tucker TC, Spanos WJ. Disparities in the application of adjuvant radiotherapy after breast-conserving surgery for early stage breast cancer: impact on overall survival. Cancer (2011) 117(12):2590–8.10.1002/cncr.25821
    1. Onega T, Cook A, Kirlin B, Shi X, Alford-Teaster J, Tuzzio L, et al. The influence of travel time on breast cancer characteristics, receipt of primary therapy, and surveillance mammography. Breast Cancer Res Treat (2011) 129(1):269–75.10.1007/s10549-011-1549-4
    1. Baldwin LM, Taplin SH, Friedman H, Moe R. Access to multidisciplinary cancer care: is it linked to the use of breast-conserving surgery with radiation for early-stage breast carcinoma? Cancer (2004) 100(4):701–9.10.1002/cncr.20030
    1. Chagpar AB, Studts JL, Scoggins CR, Martin RC, II, Carlson DJ, Laidley AL, et al. Factors associated with surgical options for breast carcinoma. Cancer (2006) 106(7):1462–6.10.1002/cncr.21728
    1. Cyran EM, Crane LA, Palmer L. Physician sex and other factors associated with type of breast cancer surgery in older women. Arch Surg (2001) 136(2):185–91.10.1001/archsurg.136.2.185
    1. Gilligan MA, Neuner J, Sparapani R, Laud PW, Nattinger AB. Surgeon characteristics and variations in treatment for early-stage breast cancer. Arch Surg (2007) 142(1):17–22.10.1001/archsurg.142.1.17
    1. Morrow M, White J, Moughan J, Owen J, Pajack T, Sylvester J, et al. Factors predicting the use of breast-conserving therapy in stage I and II breast carcinoma. J Clin Oncol (2001) 19(8):2254–62.
    1. Staradub VL, Hsieh YC, Clauson J, Langerman A, Rademaker AW, Morrow M. Factors that influence surgical choices in women with breast carcinoma. Cancer (2002) 95(6):1185–90.10.1002/cncr.10824
    1. Lautner M, Lin H, Shen Y, Parker C, Kuerer H, Shaitelman S, et al. Disparities in the use of breast-conserving therapy among patients with early-stage breast cancer. JAMA Surg (2015) 150(8):778–86.10.1001/jamasurg.2015.1102
    1. Freedman RA, Virgo KS, Labadie J, He Y, Partridge AH, Keating NL. Receipt of locoregional therapy among young women with breast cancer. Breast Cancer Res Treat (2012) 135(3):893–906.10.1007/s10549-012-2156-8
    1. Cao JQ, Olson RA, Tyldesley SK. Comparison of recurrence and survival rates after breast-conserving therapy and mastectomy in young women with breast cancer. Curr Oncol (2013) 20(6):e593–601.10.3747/co.20.1543
    1. Ye JC, Yan W, Christos PJ, Nori D, Ravi A. Equivalent survival with mastectomy or breast-conserving surgery plus radiation in young women aged < 40 years with early-stage breast cancer: a national registry-based stage-by-stage comparison. Clin Breast Cancer (2015) 15(5):390–7.10.1016/j.clbc.2015.03.012
    1. Nold RJ, Beamer RL, Helmer SD, McBoyle MF. Factors influencing a woman’s choice to undergo breast-conserving surgery versus modified radical mastectomy. Am J Surg (2000) 180(6):413–8.10.1016/S0002-9610(00)00501-8
    1. Molenaar S, Sprangers MA, Rutgers EJ, Luiten EJ, Mulder J, Bossuyt PM, et al. Decision support for patients with early-stage breast cancer: effects of an interactive breast cancer CDROM on treatment decision, satisfaction, and quality of life. J Clin Oncol (2001) 19(6):1676–87.
    1. Whelan T, Levine M, Gafni A, Sanders K, Willan A, Mirsky D, et al. Mastectomy or lumpectomy? Helping women make informed choices. J Clin Oncol (1999) 17(6):1727–35.
    1. Waljee JF, Hawley S, Alderman AK, Morrow M, Katz SJ. Patient satisfaction with treatment of breast cancer: does surgeon specialization matter? J Clin Oncol (2007) 25(24):3694–8.10.1200/JCO.2007.10.9272
    1. Ganz PA, Schag AC, Lee JJ, Polinsky ML, Tan SJ. Breast conservation versus mastectomy. Is there a difference in psychological adjustment or quality of life in the year after surgery? Cancer (1992) 69(7):1729–38.10.1002/1097-0142(19920401)69:7<1729::AID-CNCR2820690714>;2-D
    1. Collins KK, Liu Y, Schootman M, Aft R, Yan Y, Dean G, et al. Effects of breast cancer surgery and surgical side effects on body image over time. Breast Cancer Res Treat (2011) 126(1):167–76.10.1007/s10549-010-1077-7
    1. Al-Ghazal SK, Fallowfield L, Blamey RW. Comparison of psychological aspects and patient satisfaction following breast conserving surgery, simple mastectomy and breast reconstruction. Eur J Cancer (2000) 36(15):1938–43.10.1016/S0959-8049(00)00197-0
    1. Rosenberg SM, Tamimi RM, Gelber S, Ruddy KJ, Kereakoglow S, Borges VF, et al. Body image in recently diagnosed young women with early breast cancer. Psychooncology (2013) 22(8):1849–55.10.1002/pon.3221
    1. Yurek D, Farrar W, Andersen BL. Breast cancer surgery: comparing surgical groups and determining individual differences in postoperative sexuality and body change stress. J Consult Clin Psychol (2000) 68(4):697–709.10.1037/0022-006X.68.4.697
    1. Cocquyt VF, Blondeel PN, Depypere HT, Van De Sijpe KA, Daems KK, Monstrey SJ, et al. Better cosmetic results and comparable quality of life after skin-sparing mastectomy and immediate autologous breast reconstruction compared to breast conservative treatment. Br J Plast Surg (2003) 56(5):462–70.10.1016/S0007-1226(03)00198-X
    1. Fang SY, Shu BC, Chang YJ. The effect of breast reconstruction surgery on body image among women after mastectomy: a meta-analysis. Breast Cancer Res Treat (2013) 137(1):13–21.10.1007/s10549-012-2349-1
    1. Nicholson RM, Leinster S, Sassoon EM. A comparison of the cosmetic and psychological outcome of breast reconstruction, breast conserving surgery and mastectomy without reconstruction. Breast (2007) 16(4):396–410.10.1016/j.breast.2007.01.009
    1. Dian D, Schwenn K, Mylonas I, Janni W, Jaenicke F, Friese K. Aesthetic result among breast cancer patients undergoing autologous breast reconstruction versus breast conserving therapy. Arch Gynecol Obstet (2007) 275(6):445–50.10.1007/s00404-006-0270-8
    1. Morrow M, Li Y, Alderman AK, Jagsi R, Hamilton AS, Graff JJ, et al. Access to breast reconstruction after mastectomy and patient perspectives on reconstruction decision making. JAMA Surg (2014) 149(10):1015–21.10.1001/jamasurg.2014.548
    1. Sisco M, Du H, Warner JP, Howard MA, Winchester DP, Yao K. Have we expanded the equitable delivery of postmastectomy breast reconstruction in the new millennium? Evidence from the national cancer data base. J Am Coll Surg (2012) 215(5):658–66.10.1016/j.jamcollsurg.2012.07.008
    1. Morrow M, Mujahid M, Lantz PM, Janz NK, Fagerlin A, Schwartz K, et al. Correlates of breast reconstruction: results from a population-based study. Cancer (2005) 104(11):2340–6.10.1002/cncr.21444
    1. Yang RL, Newman AS, Lin IC, Reinke CE, Karakousis GC, Czerniecki BJ, et al. Trends in immediate breast reconstruction across insurance groups after enactment of breast cancer legislation. Cancer (2013) 119(13):2462–8.10.1002/cncr.28050
    1. Enewold LR, McGlynn KA, Zahm SH, Poudrier J, Anderson WF, Shriver CD, et al. Breast reconstruction after mastectomy among department of defense beneficiaries by race. Cancer (2014) 120(19):3033–9.10.1002/cncr.28806
    1. Yao K, Stewart AK, Winchester DJ, Winchester DP. Trends in contralateral prophylactic mastectomy for unilateral cancer: a report from the National Cancer Data Base, 1998-2007. Ann Surg Oncol (2010) 17(10):2554–62.10.1245/s10434-010-1091-3
    1. Tuttle TM, Habermann EB, Grund EH, Morris TJ, Virnig BA. Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment. J Clin Oncol (2007) 25(33):5203–9.10.1200/JCO.2007.12.3141
    1. King TA, Sakr R, Patil S, Gurevich I, Stempel M, Sampson M, et al. Clinical management factors contribute to the decision for contralateral prophylactic mastectomy. J Clin Oncol (2011) 29(16):2158–64.10.1200/JCO.2010.29.4041
    1. Yi M, Meric-Bernstam F, Middleton LP, Arun BK, Bedrosian I, Babiera GV, et al. Predictors of contralateral breast cancer in patients with unilateral breast cancer undergoing contralateral prophylactic mastectomy. Cancer (2009) 115(5):962–71.10.1002/cncr.24129
    1. Nichols HB, de Gonzalez AB, Lacey JV, Rosenberg PS, Anderson WF. Declining incidence of contralateral breast cancer in the United States from 1975 to 2006. J Clin Oncol (2011) 29(12):1564–9.10.1200/Jco.2010.32.7395
    1. Gao X, Fisher SG, Emami B. Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: a population-based study. Int J Radiat Oncol (2003) 56(4):1038–45.10.1016/S0360-3016(03)00203-7
    1. Neta G, Anderson WF, Gilbert E, Berrington A. Variation in the risk of radiation-related contralateral breast cancer by histology and estrogen receptor expression in SEER. Breast Cancer Res Tr (2012) 131(3):1021–7.10.1007/s10549-011-1820-8
    1. Bedrosian I, Hu CY, Chang GJ. Population-based study of contralateral prophylactic mastectomy and survival outcomes of breast cancer patients. J Natl Cancer Inst (2010) 102(6):401–9.10.1093/jnci/djq018
    1. Boughey JC, Hoskin TL, Degnim AC, Sellers TA, Johnson JL, Kasner MJ, et al. Contralateral prophylactic mastectomy is associated with a survival advantage in high-risk women with a personal history of breast cancer. Ann Surg Oncol (2010) 17(10):2702–9.10.1245/s10434-010-1136-7
    1. Kurian AW, Lichtensztajn DY, Keegan TH, Nelson DO, Clarke CA, Gomez SL. Use of and mortality after bilateral mastectomy compared with other surgical treatments for breast cancer in California, 1998-2011. JAMA (2014) 312(9):902–14.10.1001/jama.2014.10707
    1. Lostumbo L, Carbine NE, Wallace J. Prophylactic mastectomy for the prevention of breast cancer. Cochrane Database Syst Rev (2010) (11):CD002748.10.1002/14651858.CD002748.pub3
    1. Abbott A, Rueth N, Pappas-Varco S, Kuntz K, Kerr E, Tuttle T. Perceptions of contralateral breast cancer: an overestimation of risk. Ann Surg Oncol (2011) 18(11):3129–36.10.1245/s10434-011-1914-x
    1. Han E, Johnson N, Glissmeyer M, Wagie T, Carey B, DelaMelena T, et al. Increasing incidence of bilateral mastectomies: the patient perspective. Am J Surg (2011) 201(5):615–8.10.1016/j.amjsurg.2011.01.018
    1. Rosenberg SM, Tracy MS, Meyer ME, Sepucha K, Gelber S, Hirshfield-Bartek J, et al. Perceptions, knowledge, and satisfaction with contralateral prophylactic mastectomy among young women with breast cancer: a cross-sectional survey. Ann Intern Med (2013) 159(6):373–81.10.7326/0003-4819-159-6-201309170-00003
    1. Covelli AM, Baxter NN, Fitch MI, McCready DR, Wright FC. ‘Taking control of cancer’: understanding women’s choice for mastectomy. Ann Surg Oncol (2015) 22(2):383–91.10.1245/s10434-014-4033-7
    1. Yao K, Belkora J, Sisco M, Rosenberg S, Bedrosian I, Liederbach E, et al. Survey of the deficits in surgeons’ knowledge of contralateral prophylactic mastectomy. JAMA Surg (2015):1–3.10.1001/jamasurg.2015.3601
    1. Mavaddat N, Peock S, Frost D, Ellis S, Platte R, Fineberg E, et al. Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE. J Natl Cancer Inst (2013) 105(11):812–22.10.1093/jnci/djt095
    1. Meijers-Heijboer H, van Geel B, van Putten WL, Henzen-Logmans SC, Seynaeve C, Menke-Pluymers MB, et al. Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med (2001) 345(3):159–64.10.1056/NEJM200107193450301
    1. Metcalfe K, Gershman S, Lynch HT, Ghadirian P, Tung N, Kim-Sing C, et al. Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. Br J Cancer (2011) 104(9):1384–92.10.1038/bjc.2011.120
    1. van der Kolk DM, de Bock GH, Leegte BK, Schaapveld M, Mourits MJ, de Vries J, et al. Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: high cancer incidence at older age. Breast Cancer Res Treat (2010) 124(3):643–51.10.1007/s10549-010-0805-3
    1. Reiner AS, John EM, Brooks JD, Lynch CF, Bernstein L, Mellemkjaer L, et al. Risk of asynchronous contralateral breast cancer in noncarriers of BRCA1 and BRCA2 mutations with a family history of breast cancer: a report from the Women’s Environmental Cancer and Radiation Epidemiology Study. J Clin Oncol (2013) 31(4):433–9.10.1200/JCO.2012.43.2013
    1. Stuckey AR, Onstad MA. Hereditary breast cancer: an update on risk assessment and genetic testing in 2015. Am J Obstet Gynecol (2015) 213(2):161–5.10.1016/j.ajog.2015.03.003

Source: PubMed

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

3
Subskrybuj